Apparent Commercial Bias in Supplement

Letter to the Editor

Sir: I read your recent supplement " Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap" with interest.

As a practicing psychiatrist with experience prescribing the full range of antipsychotics, I recognize the need for detailed information to help clinicians decide among the many choices in our armamentarium. While the supplement was published to address this need, I have serious questions regarding its scientific integrity.